KETOROL DT TABLET 15'S

No, KETOROL DT TABLET 15'S is neither an antibiotic nor a steroid. It belongs to non-steroidal anti-inflammatory drugs (NSAIDs) group of medicines. It is used to relieve moderate to severe pain and inflammation.

KETOROL DT TABLET 15'S is effective in relieving pain and inflammation. It is used to provide relief from various sorts of pain, such as sprains, strains and other injuries. It is also helpful in the treatment of different types of arthritis and gout. Along with that, it can be used to reduce pain and inflammation which follows after a surgery.

KETOROL DT TABLET 15'S is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.

If you forget a dose of KETOROL DT TABLET 15'S, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take the next scheduled dose in the prescribed time. Do not double the dose to make up for the missed one as this may increase the chances of developing side effects.

KETOROL DT TABLET 15'S is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using KETOROL DT TABLET 15'S too early, the symptoms may return or worsen.

Some common side effects associated with KETOROL DT TABLET 15'S include vomiting, stomach pain, nausea and indigestion. However, these side effects are usually not bothersome and resolve in some time. If they persist for a longer duration or worry you, consult your doctor.

Ketorol DT is used for short-term management of moderate to severe acute pain. Typical indications include postoperative pain (such as after orthopedic, abdominal, or gynecological surgery), dental pain (for example after tooth extraction), and acute musculoskeletal pain due to sprains, strains, or trauma. It is not intended for long-term treatment of chronic pain conditions or for mild, self-limiting pain.

Ketorol DT is a painkiller, not an antibiotic. It belongs to the non-steroidal anti-inflammatory drug (NSAID) class and works by reducing prostaglandin production to relieve pain and inflammation. It has no activity against bacteria, viruses, or other infectious agents, so it should not be used to treat infections.

Ketorol DT may be prescribed by a doctor for severe headache or migraine attacks when they judge that a short course of ketorolac is appropriate. However, it is not usually the first-line medicine for routine headaches or recurrent migraines because of its potential for serious gastrointestinal and renal side effects. Patients should not self-medicate with Ketorol DT for frequent headaches without medical evaluation.

Ketorolac, the active ingredient in Ketorol DT, is recommended only for short-term use. In most guidelines, the total duration of therapy, including any injectable and oral forms, should not exceed a few days. Prolonged use significantly increases the risk of stomach ulcers, gastrointestinal bleeding, kidney damage, and cardiovascular events. The exact duration for an individual patient must be determined by the prescribing clinician, and you should not extend the course on your own.

Ketorol DT can technically be taken with or without food, but taking it with food, milk, or immediately after a meal may help reduce stomach irritation and dyspepsia. Because ketorolac can cause gastritis, ulcers, and bleeding, patients with a history of peptic ulcer disease, gastritis, or acid reflux should be especially cautious and follow their doctor’s advice, which may include taking gastroprotective medication alongside Ketorol DT.

Ketorol DT should be used with great caution, or avoided, in patients with kidney impairment. Ketorolac can reduce renal blood flow and may worsen existing kidney dysfunction or precipitate acute kidney injury, especially in dehydrated patients, older adults, or those taking diuretics, ACE inhibitors, or angiotensin receptor blockers. In moderate to severe renal impairment, ketorolac is generally contraindicated. Patients with any kidney disease must consult their nephrologist or treating physician before using Ketorol DT.

Ketorol DT is generally not recommended during pregnancy, particularly in the third trimester. NSAIDs like ketorolac can cause premature closure of the fetal ductus arteriosus, fetal renal impairment, oligohydramnios, and increased risk of bleeding in both mother and baby. Use in the first and second trimesters is also usually avoided unless the potential benefit clearly outweighs the risks and no safer alternative is available. Pregnant women should seek obstetric advice before taking Ketorol DT or any strong NSAID.

Ketorolac passes into breast milk in small amounts. Short-term use of ketorolac immediately after delivery is sometimes practiced under strict medical supervision, but routine or prolonged use during breastfeeding is generally discouraged due to limited safety data and potential risk of adverse effects in the infant, such as gastrointestinal irritation or renal effects. A breastfeeding mother should only use Ketorol DT if specifically advised by her doctor, who may consider alternative analgesics with a more established safety profile in lactation.

Combining Ketorol DT with alcohol is not advisable. Both alcohol and ketorolac can irritate the stomach lining and increase the risk of gastritis, ulcers, and gastrointestinal bleeding. Alcohol may also enhance dizziness or drowsiness associated with Ketorol DT, impairing alertness and coordination. Patients should avoid or strictly limit alcohol intake during treatment and discuss their alcohol use with their healthcare provider.

Patients should seek urgent medical attention if they experience symptoms suggestive of serious adverse effects, such as black, tarry, or bloody stools; vomiting blood or material that looks like coffee grounds; severe or persistent abdominal pain; sudden shortness of breath; chest pain; weakness on one side of the body; slurred speech; marked reduction in urine output; swelling of the face, lips, tongue, or throat; severe skin rash or blistering; or sudden wheezing or difficulty breathing. These may indicate gastrointestinal bleeding, cardiovascular events, kidney injury, or severe allergic reactions.

Ketorol DT should not be combined with other NSAIDs (such as ibuprofen, diclofenac, naproxen, or high-dose aspirin) because this significantly increases the risk of gastrointestinal bleeding, kidney damage, and other adverse effects without providing proportional additional benefit. In some cases, a doctor may prescribe Ketorol DT along with paracetamol (acetaminophen) or certain adjuvant analgesics to enhance pain control. Any combination therapy should be guided by a healthcare professional, and patients should inform their doctor about all over-the-counter and prescription medicines they are using.